Literature DB >> 21833504

Protracted manifestations of acute dependence after a single morphine exposure.

Patrick E Rothwell1, Mark J Thomas, Jonathan C Gewirtz.   

Abstract

RATIONALE: Acute opiate exposure produces a state of dependence in humans and animals, which is revealed by signs and symptoms of withdrawal precipitated by opioid receptor antagonists. The physiological changes that underlie this state of acute dependence develop rapidly and can persist long after the end of chronic opiate exposure.
OBJECTIVES: The purpose of this investigation was to determine the persistence of acute dependence after a single morphine exposure in rodents, focusing on changes in behavior thought to reflect the negative emotional consequences of withdrawal.
METHODS: The acoustic startle reflex and conditioned place aversion were measured following naloxone administration at different time points after a single morphine exposure.
RESULTS: Naloxone administration produced significant potentiation of acoustic startle-a form of anxiety-like behavior-for at least 80 days after one exposure to morphine. In contrast, naloxone produced a conditioned place aversion 24 h but not 20 days after one morphine exposure.
CONCLUSIONS: Together with existing literature, these results suggest acute as well as chronic opiate exposure leave rodents persistently vulnerable to express anxiety-like behavior in response to opioid receptor antagonists or stressful experience. The adaptations in brain function that underlie this protracted state of dependence may provide a foundation for the escalation of withdrawal severity that develops over repeated opiate exposure, and increase the likelihood of progression from casual drug use to compulsive drug abuse.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21833504      PMCID: PMC3978778          DOI: 10.1007/s00213-011-2425-y

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  74 in total

1.  Place conditioning to study drug reward and aversion.

Authors:  William A Carlezon
Journal:  Methods Mol Med       Date:  2003

2.  Methadone patients exhibit increased startle and cortisol response after intravenous yohimbine.

Authors:  S M Stine; C G Grillon; C A Morgan; T R Kosten; D S Charney; J H Krystal
Journal:  Psychopharmacology (Berl)       Date:  2001-03       Impact factor: 4.530

Review 3.  Addiction and the brain antireward system.

Authors:  George F Koob; Michel Le Moal
Journal:  Annu Rev Psychol       Date:  2008       Impact factor: 24.137

Review 4.  Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues.

Authors:  T M Tzschentke
Journal:  Prog Neurobiol       Date:  1998-12       Impact factor: 11.685

5.  Pharmacologic characterization of the sensitization to the rate-decreasing effects of naltrexone induced by acute opioid pretreatment in rats.

Authors:  J U Adams; S G Holtzman
Journal:  J Pharmacol Exp Ther       Date:  1990-05       Impact factor: 4.030

6.  Impaired emotional-like behavior and serotonergic function during protracted abstinence from chronic morphine.

Authors:  Celia Goeldner; Pierre-Eric Lutz; Emmanuel Darcq; Thomas Halter; Daniel Clesse; Abdel-Mouttalib Ouagazzal; Brigitte L Kieffer
Journal:  Biol Psychiatry       Date:  2010-10-14       Impact factor: 13.382

7.  Discrimination of a single dose of morphine followed by naltrexone: substitution of other agonists for morphine and other antagonists for naltrexone in a rat model of acute dependence.

Authors:  Stephen G Holtzman
Journal:  J Pharmacol Exp Ther       Date:  2003-03       Impact factor: 4.030

8.  Relative sensitivity to naloxone of multiple indices of opiate withdrawal: a quantitative dose-response analysis.

Authors:  G Schulteis; A Markou; L H Gold; L Stinus; G F Koob
Journal:  J Pharmacol Exp Ther       Date:  1994-12       Impact factor: 4.030

Review 9.  Neural substrates of opiate withdrawal.

Authors:  G F Koob; R Maldonado; L Stinus
Journal:  Trends Neurosci       Date:  1992-05       Impact factor: 13.837

10.  Anxiolytic-like effects of morphine and buprenorphine in the rat model of fear-potentiated startle: tolerance, cross-tolerance, and blockade by naloxone.

Authors:  Ebony M Glover; Michael Davis
Journal:  Psychopharmacology (Berl)       Date:  2008-03-07       Impact factor: 4.530

View more
  9 in total

Review 1.  Motivational Processes Underlying Substance Abuse Disorder.

Authors:  Paul J Meyer; Christopher P King; Carrie R Ferrario
Journal:  Curr Top Behav Neurosci       Date:  2016

2.  Rimonabant precipitates anxiety in rats withdrawn from palatable food: role of the central amygdala.

Authors:  Angelo Blasio; Attilio Iemolo; Valentina Sabino; Stefania Petrosino; Luca Steardo; Kenner C Rice; Pierangelo Orlando; Fabio Arturo Iannotti; Vincenzo Di Marzo; Eric P Zorrilla; Pietro Cottone
Journal:  Neuropsychopharmacology       Date:  2013-06-24       Impact factor: 7.853

3.  Corticotropin-releasing factor (CRF) and α 2 adrenergic receptors mediate heroin withdrawal-potentiated startle in rats.

Authors:  Paula E Park; Leandro F Vendruscolo; Joel E Schlosburg; Scott Edwards; Gery Schulteis; George F Koob
Journal:  Int J Neuropsychopharmacol       Date:  2013-04-16       Impact factor: 5.176

Review 4.  Opioid and Psychostimulant Plasticity: Targeting Overlap in Nucleus Accumbens Glutamate Signaling.

Authors:  Matthew Hearing; Nicholas Graziane; Yan Dong; Mark J Thomas
Journal:  Trends Pharmacol Sci       Date:  2018-01-12       Impact factor: 14.819

5.  Accounting for the uncounted: Physical and affective distress in individuals dropping out of oral naltrexone treatment for opioid use disorder.

Authors:  Kathleen M Carroll; Charla Nich; Tami L Frankforter; Sarah W Yip; Brian D Kiluk; Elise E DeVito; Mehmet Sofuoglu
Journal:  Drug Alcohol Depend       Date:  2018-10-04       Impact factor: 4.492

Review 6.  The Negative Affect of Protracted Opioid Abstinence: Progress and Perspectives From Rodent Models.

Authors:  Lola Welsch; Julie Bailly; Emmanuel Darcq; Brigitte Lina Kieffer
Journal:  Biol Psychiatry       Date:  2019-08-06       Impact factor: 13.382

Review 7.  Neurodevelopmental origins of substance use disorders: Evidence from animal models of early-life adversity and addiction.

Authors:  Sophia C Levis; Tallie Z Baram; Stephen V Mahler
Journal:  Eur J Neurosci       Date:  2021-04-25       Impact factor: 3.698

Review 8.  It's MORe exciting than mu: crosstalk between mu opioid receptors and glutamatergic transmission in the mesolimbic dopamine system.

Authors:  Elena H Chartoff; Hilary S Connery
Journal:  Front Pharmacol       Date:  2014-05-27       Impact factor: 5.810

Review 9.  Molecular and neuronal plasticity mechanisms in the amygdala-prefrontal cortical circuit: implications for opiate addiction memory formation.

Authors:  Laura G Rosen; Ninglei Sun; Walter Rushlow; Steven R Laviolette
Journal:  Front Neurosci       Date:  2015-11-05       Impact factor: 4.677

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.